A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT. . Equipo Investigadores: CALONGE CANO, MARGARITA (IP); BLAZQUEZ ARAUZO, FRANCISCO; GARCIA VAZQUEZ, MARIA DEL CARMEN; BLANCO VAZQUEZ, MARTA; HERRERAS CANTALAPIEDRA, JOSE MARIA; VALENCIA NIETO, LAURA; ENRIQUEZ DE SALAMANCA ALADRO, AMALIA; ARLANZON LOPE, PABLO; FERNANDEZ MARTINEZ, ITZIAR; PINTO FRAGA, FRANCISCO JOSE; GONZÁLEZ-GARCÍA, MARÍA J.; LOPEZ MIGUEL, ALBERTO. Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: SANTEN SA.. 29/04/2019
|